Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $16.6800 (-0.06%) ($16.6800 - $16.6800) on Fri. Dec. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.82% (three month average) | RSI | 34 | Latest Price | $16.6800(-0.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.3% a day on average for past five trading days. | Weekly Trend | TGTX declines -16.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(76%) ARKG(70%) IBB(67%) ARKK(65%) IWO(63%) | Factors Impacting TGTX price | TGTX will decline at least -2.91% in a week (0% probabilities). VIXM(-47%) VXX(-40%) UUP(-24%) UNG(-9%) USO(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.91% (StdDev 5.82%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-20.78(-224.58%) | Resistance Level | $21.28 | 5 Day Moving Average | $17.06(-2.23%) | 10 Day Moving Average | $17.15(-2.74%) | 20 Day Moving Average | $21.28(-21.62%) | To recent high | -53.1% | To recent low | 9.9% | Market Cap | $2.113b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |